INTRODUCTION AND HYPOTHESIS: In this study, the impact of mid-urethral slings (MUS) on incontinence-related distress, quality of life and sexual function is assessed at a minimum 2 years. METHODS: Patients received either a pubovaginal sling (PVS) or a tension-free vaginal tape (TVT). The Arabic translation of urogenital distress inventory (UDI)-6, incontinence impact questionnaire (IIQ)-7, and short form Female Sexual Function Index (FSFI) were administered at baseline and 24 months. RESULTS:Sixty three women with a mean age of 47.8 years were included in this study. A median follow-up was done after 54 ± 21.9 months. Thirty nine women had PVS while 24 had TVT. Cure was defined as a significant decrease in UDI-6 and a negative stress test at 200 ml, which was found to be 93.65% and 95.2%, respectively. Overall, UDI-6 decreased from a mean preoperative value of 68.1 ± 16.9 to 27.6 ± 18.3 (p < 0.0001). IIQ-7 decreased from 70 ± 19 to 24 ± 20.8(p < 0.0001). The difference between pre- and postoperative values was insignificant. CONCLUSION: An MUS gives a cure rate of over 93% at a median follow-up of 54 months. A significant decline in UDI-6 and IIQ-7 is evident after surgery. Sexual function, as measured by the FSFI, was not significantly affected.
RCT Entities:
INTRODUCTION AND HYPOTHESIS: In this study, the impact of mid-urethral slings (MUS) on incontinence-related distress, quality of life and sexual function is assessed at a minimum 2 years. METHODS:Patients received either a pubovaginal sling (PVS) or a tension-free vaginal tape (TVT). The Arabic translation of urogenital distress inventory (UDI)-6, incontinence impact questionnaire (IIQ)-7, and short form Female Sexual Function Index (FSFI) were administered at baseline and 24 months. RESULTS: Sixty three women with a mean age of 47.8 years were included in this study. A median follow-up was done after 54 ± 21.9 months. Thirty nine women had PVS while 24 had TVT. Cure was defined as a significant decrease in UDI-6 and a negative stress test at 200 ml, which was found to be 93.65% and 95.2%, respectively. Overall, UDI-6 decreased from a mean preoperative value of 68.1 ± 16.9 to 27.6 ± 18.3 (p < 0.0001). IIQ-7 decreased from 70 ± 19 to 24 ± 20.8(p < 0.0001). The difference between pre- and postoperative values was insignificant. CONCLUSION: An MUS gives a cure rate of over 93% at a median follow-up of 54 months. A significant decline in UDI-6 and IIQ-7 is evident after surgery. Sexual function, as measured by the FSFI, was not significantly affected.
Authors: Daniel M Morgan; Rodney L Dunn; Dee E Fenner; Gary Faerber; John O L DeLancey; Edward J McGuire; John T Wei Journal: J Urol Date: 2007-02 Impact factor: 7.450
Authors: S L Tennstedt; H J Litman; P Zimmern; C Ghetti; J W Kusek; C W Nager; E R Mueller; S R Kraus; E Varner Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-08-06
Authors: Miles Murphy; Heather van Raalte; Eduardo Mercurio; Robin Haff; Barbara Wiseman; Vincent R Lucente Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2007-10-17
Authors: Tanya M Nazemi; Brian Yamada; Fred E Govier; Dimitri D Kuznetsov; Koichi Kodama; Kathleen C Kobashi Journal: J Urol Date: 2007-12-21 Impact factor: 7.450
Authors: Jerry G Blaivas; Rajveer S Purohit; Matthew S Benedon; Gabriel Mekel; Michael Stern; Mubashir Billah; Kola Olugbade; Robert Bendavid; Vladimir Iakovlev Journal: Nat Rev Urol Date: 2015-08-18 Impact factor: 14.432
Authors: Nicole Szell; Barry Komisaruk; Sue W Goldstein; Xianggui Harvey Qu; Michael Shaw; Irwin Goldstein Journal: Sex Med Date: 2017-03-28 Impact factor: 2.491